From advanced manufacturing in Warsaw to biopharma breakthroughs in Bloomington, Indiana’s life sciences ecosystem is made up of distinct regional hubs—each contributing in unique ways to the state’s national leadership.
Through in-depth market research, BioCrossroads uncovers opportunities to fuel collaborative efforts that enhance our innovations and advancements on a global scale.
We fuel startups and entrepreneurs by providing a supportive ecosystem of mentorship and identifying funding support.
By collaborating with Indiana’s research institutions, global companies, philanthropic organizations, and government, we connect Indiana’s life sciences community and work to accelerate its success.
The 2024 BioCrossroads Life Sciences Summit, “Transforming Healthcare: Indiana’s Role in Revolutionizing Diabetes and Obesity Management,” brought together leaders from across Indiana and beyond, highlighting the groundbreaking advancements that are transforming how we address these conditions.
A full recap of the event coming soon.
FrameWORX is a dynamic educational series that serves as a platform for growth, learning, and connectivity within Indiana’s thriving life sciences ecosystem. These events take place throughout the year and provide a hub for engaging thought leaders, offering diverse viewpoints, and fostering enhanced collaboration among the state’s research institutions, philanthropic organizations, and enterprises.
Join us for an engaging exploration into the growing potential of Indiana’s life sciences workforce. This FrameWORX will dive into strategic initiatives aimed at enhancing talent development and recruitment across the state’s thriving life sciences sector. Discover how these efforts align with our broader goals to solidify Indiana as a leader in life sciences innovation and manufacturing.
In 2023, BioCrossroads solidified its commitment to enhancing Indiana’s reputation as a global leader in life sciences, marking a year of unprecedented innovation, collaboration, and growth.
BioCrossroads, in collaboration with TEConomy Partners and key industry stakeholders, worked to develop a refreshed 10-year strategy for the industry. The Strategic Framework for Advancing Indiana’s Life Sciences Industry provides a roadmap for elevating Indiana’s life sciences sector and enhancing our global impact on the ecosystem.
statewide economic contribution
of Indiana’s economic activity
in pharmaceutical exports
in life sciences exports
BioCrossroads is one of five Central Indiana Corporate Partnership branded initiatives. In addition to its sister initiatives, there are several other resources for the life sciences community.
Through in-depth research and analysis of Indiana’s life sciences sector, BioCrossroads, in partnership with research institutions, provides comprehensive reports and resources to help educate, inform, and share the story of our industry’s impact.
BioCrossroads has transformed its Book of Data and Organizations into a fully digital “wiki” for Indiana’s health data assets. This resource was developed alongside Indiana University data science students to help streamline information sharing for more than 50 enterprises across industry, government, health systems, academia, and startups.
The 2023 Indiana Life Sciences Summit, hosted by BioCrossroads, spotlighted Indiana’s leadership role in research and medical advances related to Alzheimer’s disease.
Indiana’s vibrant and uniquely collaborative life sciences industry boasts statistics that rival coastal hubs of activity and has gained national recognition for leadership.
Use the links below to learn more and connect with companies.
Allied OSI Labs
Ambu
American Renolit Corp
American Ultraviolet
AO Safety
Arcamed
Argon Medical Devices
Avalign Cutting Instruments
Bangs Laboratories
Beckman Coulter Life Sciences
BioMericsATL
Boston Scientific
C&A Tool Engineering
Champion Manufacturing
Complexus Medical
Cook Biotech
Cook Medical
Cook Regentec
DePuy-Synthes Orthopaedics
EHOB
Esaote North America
Fort Wayne Metals
Freudenberg Medical
G&H Wire
Genesis Manufacturing
Glas-Col LLC
GMI
Greenlight Guru
Helmer
Heraeus Kulzer
Hill-Rom
Indigo Bioautomation
Instrumedical Technologies
Integer (Greatbatch Medical)
Mectra Labs
Medical Polymers
Medtronic
Micropulse
Nextremity Solutions
Nexxt Spine
Nico Corporation
Orthopediatrics
Paragon Medical
Parker Medical Systems
Piezo Technologies
Point Medical
Precision Medical Technologies
PTS Diagnostics
Pulmodyne
RND Group
Roche Diagnostics
Siemens Healthineers
Smith & Nephew
Smiths Medical
Stryker Orthopaedics
T P Orthodontics Inc
Tecomet
Vasc-Alert
Wright Medical
Xeno Diagnostics
Zimmer Biomet
Sign up for the monthly BioCrossroads Newsletter and get the latest industry updates and insights delivered to your inbox.
30 life sciences companies have received investments from the seed funds managed by BioCrossroads and have gone on to raise more than a half-billion dollars in additional venture investment.
Significant exits include Calibrium and MB2, both acquired by Novo Nordisk in 2015, Assembly Biosciences (Nasdaq:ASMB), and Sexton Biotechnologies, purchased by BioLife Solutions (Nasdaq:BLFS) in 2021.
Here’s a look at selected companies that have benefited from Indiana seed fund investments.
Doors open at 3 p.m.
Please join us at your earliest convenience to enjoy our complimentary bar and networking ahead of the program.
Join us for refreshments and additional networking following the discussion.